These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 39084578)

  • 1. Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score.
    Cheng LJ; Chen LA; Cheng JY; Herdman M; Luo N
    J Clin Epidemiol; 2024 Oct; 174():111487. PubMed ID: 39084578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer.
    Bourke S; Bennett B; Oluboyede Y; Li T; Longworth L; O'Sullivan SB; Braverman J; Soare IA; Shaw JW
    Health Qual Life Outcomes; 2024 Sep; 22(1):81. PubMed ID: 39304893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes.
    McClure NS; Sayah FA; Ohinmaa A; Johnson JA
    Value Health; 2018 Sep; 21(9):1090-1097. PubMed ID: 30224114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness.
    Lin DY; Cheok TS; Kaambwa B; Samson AJ; Morrison C; Chan T; Kroon HM; Jaarsma RL
    Health Qual Life Outcomes; 2023 May; 21(1):41. PubMed ID: 37165364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients.
    Siriwardana AN; Hoffman AT; Morton RL; Smyth B; Brown MA
    Value Health; 2024 Apr; 27(4):469-477. PubMed ID: 38307389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally important difference and predictors of change in quality of life in type 2 diabetes: A community-based survey in China.
    Jin X; Liu GG; Gerstein HC; Levine MAH; Guan H; Li H; Xie F
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3053. PubMed ID: 30064154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness and minimal clinically important difference of the EQ-5D-5L in cervical intraepithelial neoplasia: a longitudinal study.
    Hu X; Jing M; Zhang M; Yang P; Yan X
    Health Qual Life Outcomes; 2020 Oct; 18(1):324. PubMed ID: 33008423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scoping review of the use of minimally important difference of EQ-5D utility index and EQ-VAS scores in health technology assessment.
    Shaw C; Longworth L; Bennett B; McEntee-Richardson L; Shaw JW
    Health Qual Life Outcomes; 2024 Aug; 22(1):63. PubMed ID: 39135171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
    Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.
    Harvie HS; Honeycutt AA; Neuwahl SJ; Barber MD; Richter HE; Visco AG; Sung VW; Shepherd JP; Rogers RG; Jakus-Waldman S; Mazloomdoost D;
    Am J Obstet Gynecol; 2019 Mar; 220(3):265.e1-265.e11. PubMed ID: 30471259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference.
    Nolan CM; Longworth L; Lord J; Canavan JL; Jones SE; Kon SS; Man WD
    Thorax; 2016 Jun; 71(6):493-500. PubMed ID: 27030578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing the minimal clinically important difference of the EQ-5D-3L in older adults with a history of falls.
    Jehu DA; Davis JC; Madden K; Parmar N; Liu-Ambrose T
    Qual Life Res; 2022 Nov; 31(11):3293-3303. PubMed ID: 35999431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores.
    McClure NS; Sayah FA; Xie F; Luo N; Johnson JA
    Value Health; 2017 Apr; 20(4):644-650. PubMed ID: 28408007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
    Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
    J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
    Tsai APY; Hur SA; Wong A; Safavi M; Assayag D; Johannson KA; Morisset J; Fell C; Fisher JH; Manganas H; Shapera S; Cox G; Gershon AS; Hambly N; Khalil N; To T; Wilcox PG; Halayko A; Kolb MR; Ryerson CJ
    Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
    Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
    Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols.
    Henry EB; Barry LE; Hobbins AP; McClure NS; O'Neill C
    Value Health; 2020 Jul; 23(7):936-944. PubMed ID: 32762996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.